LSWClass II
Anti-Dna Antibody, Antigen And Control
21 CFR 866.5100 / Immunology
LSW is the FDA product code for Anti-Dna Antibody, Antigen And Control, a class II device type, regulated under 21 CFR 866.5100. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- LSW
- Device name
- Anti-Dna Antibody, Antigen And Control
- Regulation
- 21 CFR 866.5100
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 1
Clearances, product code LSW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1987 | 1 |
| 1993 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2016 | 1 |
| 2018 | 1 |
Applicants with the most clearances
Product code LSW| Applicant | Clearances |
|---|---|
| Aesku Diagnostics | 2 |
| Aesku.Diagnostics GmbH & Co. KG | 1 |
| Biomedical Diagnostics (Bmd) SA | 1 |
| Immco Diagnostics, Inc. | 1 |
| Immunodiagnostics, Ltd. | 1 |
| Inova Diagnostics, Inc. | 1 |
| Phadia AB | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
